MENU

DDB welcomes additional budget for support to treatment and rehabilitation

The Dangerous Drugs Board expressed its gratitude to the House of Representatives for the additional P240 million budget for the establishment of community based treatment and rehabilitation facilities all over the country. This was included in House Bill 4228 or General Appropriations Act of 2020.

Read more ...

DDB vows to support the implementation of recommendations presented during the nat’l drugs summit

The Dangerous Drugs Board, in partnership with the Supreme Court and Philippine Judicial Academy convened representatives of the executive, legislative and the judiciary for a National Summit on Dangerous Drugs Law last Thursday, October 3, at the Manila Hotel.

Read more ...

DDB Lauds Filipino’s Support for the Anti-Illegal Drugs Campaign

The Dangerous Drugs Board (DDB) welcomes the latest SWS Survey showing an 82% satisfaction rate on the government’s campaign against illegal drugs in the country.

Read more ...

DOST joins DDB, other government agencies in the implementation of PADS

The Dangerous Drugs Board (DDB) led the institutionalization of the Philippine Anti-Illegal Drugs Strategy to the Department of Science and Technology (DOST) through the Orientation-Workshop for DOST Central Office, Regional Offices, and Attached Agencies.

Read more ...

PHILIPPINES TO ASSUME AS CHAIR OF THE TREATMENT AND REHABILITATION CLUSTER OF THE ASEAN SENIOR OFFICIALS ON DRUG MATTERS

In Photo: The Philippines officially accepts the chairmanship of the Treatment and Rehabilitation Cluster of the ASEAN Senior Officials on Drug Matters from Director General Dato’ Sri Zulkifli Bin Abdullah of the National Anti-Drugs Agency of Malaysia.

Senior officials from the Dangerous Drugs Board (DDB) and the Philippine Drug Enforcement Agency (PDEA) are in Siem Reap, Cambodia for the 40th Meeting of ASEAN Senior Officials on Drug Matters (ASOD). The annual high-level discussion provides a platform for significant international and regional cooperation highlighting important aspects of the ASEAN Work Plan in Securing Communities Against Illicit Drugs. Concerns range from Law Enforcement, Preventive Education, Alternative Development, Treatment and Rehabilitation to Research.

Read more ...

DDB convenes SK Federation Presidents in General Santos City

After the passage of the SK Reform Law, the Dangerous Drugs Board puts premium to drug abuse prevention education as a way of strengthening the commitment of the Sangguniang Kabataan in President Rodrigo Roa Duterte’s campaign against illegal drugs.

Read more ...

DDB Statement on the adoption of Iceland’s Resolution at the United Nations Human Rights Council

The Dangerous Drugs Board (DDB) expresses its dismay at the ill-informed action of the United Nations Human Rights Council (UNHRC) to proceed with its preliminary investigation on the violations which have purportedly been committed by the Government of the Republic of the Philippines in the course of its campaign against illegal drugs.

Read more ...

DDB recognizes secondary schools with outstanding anti-drug program for the youth

The Dangerous Drugs Board (DDB) holds an awarding ceremony to recognize winners of the Search for Outstanding Barkada Kontra Droga (BKD) implementers in secondary schools today, July 12, at Richmonde Hotel, Ortigas City.

Read more ...

DDB statement on the UN Resolution to investigate alleged “drug killings” in the Philippines

The Dangerous Drugs Board denounces the draft resolution filed by Iceland at the United Nations Human Rights Council (UNHCR) to investigate drug-related killings in the Philippines.

Read more ...

PROFILE OF DRUG ABUSERS
(Facility Based)
CY 2011

AGE : Mean age of 29 years
SEX : Ratio of male to female 9:1
CIVIL STATUS : Single 51.94%
STATUS OF EMPLOYMENT : Unemployed 35.16%
EDUCATIONAL ATTAINMENT : College Level 30.23%
ECONOMIC STATUS : Average Monthly Family Income Php 15,818.10
PLACE OF RESIDENCE : Urban (Specifically NCR 48.42%)
DURATION OF DRUG - TAKING : More than six (6) years
NATURE OF DRUG - TAKING : Poly drug use**
DRUGS/SUBSTANCES OF ABUSE :
                                         Methamphetamine Hydrochloride (Shabu)
                                         Cannabis (Marijuana)
                                         Inhalants (Contact Cement Adhesive)

*Residential and Out-Patient Facilities
**Poly drug users - abuse of more than one (1) drug

REPORTED CASES BY GENDER
(Facility Based)*
CY 2011

                                                   MALE                FEMALE         GRAND TOTAL
TYPE OF ADMISSION No. % No. % No. %
NEW ADMISSION 2,148  70.66  246  8.09  2,394  78.75 
RE-ADMISSION  410 13.49  15  0.49  425  13.98 
OUT-PATIENT  190  6.25  31  1.02  221  7.27 
TOTAL  2,748  90.39  292  9.61  3,040  100.00 

* Total Reported Cases from Residential and Out-Patient Facilities

DRUG ABUSE TREND: 2011 ANALYSIS

       For the year 2011, thirty (30) residential treatment and three (3) outpatient facilities reported to the Integrated Drug Abuse Data and Information Network (IDADIN). These facilities reported a total admission of 3,040 drug cases. Of this number, 78.75% or 2,394 were new admission, 13.98% or 425 were relapse cases and 7.27% or 221 were referrals from outpatient facilities.

       A 10.75% increase was recorded from previous year. The increase may be attributable to the intensified advocacy program done by the government to convince families that those who have drug problems need to undergo treatment and rehabilitation. On the other hand, the increase on the arrests of users based on the intensified operations conducted by the law enforcement on pushers/users
may also have contributed to the increase of admission in the treatment and rehabilitation facilities

* Reported Cases from Residential and Out-Patient Facilities

 
MOST COMMONLY USED/ABUSED DRUGS/SUBSTANCES
(Facility Based)*
CY 2011
DRUGS USED / ABUSED NEW ADMISSION RE-ADMISSION OUT-PATIENT GRAND TOTAL % based on the total number of responses (3,692) % based on the total number of admissions (3,040)
1. Methamphetamine Hydrochloride(Shabu) 1,812 380 116 2,308 62.51 75.92
2. Cannabis (Marijuana) 767 136 89 992 26.87 32.63
3. Inhalants (Contact Cement, Adhesive) 156 10 9 175 4.74 5.76
4. Benzodiazepines (Diazepam) 41 14 3 58 1.57 1.91
5. Cocaine 37 13   50 1.35 1.64
6. Solvent 16   15 31 0.84 1.02
7. Nalbuphine Hydrochloride (Nubain) 25 3   28 0.76 0.92
8. MDMA (Ecstasy) 18 9   27 0.73 0.89

*  Reported Cases from Residential and Out-Patient Facilities